Early-phase analytical support for pharmaceutical and nutraceutical R&D — feasibility studies, ingredient comparability, screening assays and structural confirmation. Pragmatic, fit-for-purpose work that gets you to the next decision gate.
Identity and structural confirmation of synthesis intermediates
Comparability between supplier batches and reference standards
Feasibility-stage stability and forced-degradation screening
Bioactivity-assay support and method scouting
Solubility, logP and physicochemical characterisation
Hit-to-lead analytical de-risking
Method scouting for downstream development
Analytical advice on candidate selection
Method scouting, comparability and purity profiling.
Mass confirmation, fragment interpretation and impurity ID.
Structural confirmation for novel chemical entities.
Functional-group screening and qualitative comparison.
Water content for moisture-sensitive intermediates.
Acid, base, oxidation, heat and light to identify potential stability liabilities early.
Methods, documentation and acceptance criteria are designed to align with the standards below. This describes design intent — formal accreditations are listed on the About page.
Concise study reports tailored to the decision being made
Annotated chromatograms and spectra
Comparability tables for batch-to-batch evaluation
Risk register for compounds entering development
Recommendation memos for candidate progression
Raw data delivered alongside summary
Send a short scope and we'll come back with a quote and indicative timeline within one working day.